Back to Index

Pamela L. Zeitlin, M.D., Ph.D., Named Director of Pediatric Pulmonology at Johns Hopkins 
Pamela L. Zeitlin, M.D, Ph.D., professor of pediatrics at the Johns Hopkins Children's Center, has been named Director of the Eudowood Division of Pediatric Respiratory Sciences.

Zeitlin will direct research and teaching programs and patient care for the division, which includes the Cystic Fibrosis Research Development Center, Pediatric Sleep and Breathing Disorders Center, Gene Therapy Research Center, and Pediatric Lung Transplantation Program.

As director, Zeitlin says her top priorities will include building on the division's strong fellowship training program, fostering the careers of current and incoming pediatric pulmonologists, and providing consultation services to both patients and pediatricians in the Baltimore metropolitan area. Zeitlin succeeds Gerald M. Loughlin, M.D., who was named Chairman of Pediatrics at New York Weill Cornell Children's Hospital of New York-Presbyterian.

A Children's Center faculty member since 1989, Zeitlin received both her medical and doctoral degrees from Yale University, and completed her pediatrics internship, residency, and fellowship at the Johns Hopkins Children's Center. She is currently the co-director of the hospital's Cystic Fibrosis Clinical Center and the associate director of the Pediatric General Clinical Research Center.
"Dr. Zeitlin's clinical and research contributions, particularly in gene therapy to treat cystic fibrosis, have made her a leader in the field of pediatric pulmonary medicine," says George J. Dover, M.D., director of the Children's Center. "Her experience, knowledge and dedication ensure that the division will continue to thrive and grow under her leadership."

Zeitlin will continue her cystic fibrosis research and remain the primary investigator for the Cystic Fibrosis Foundation Therapeutic Development Network at Johns Hopkins. Hopkins is one of eight centers across the country involved in the network, which is designed to expedite the early phases of clinical trials that evaluate safety and dosing regimens for new cystic fibrosis drugs and treatments.

Zeitlin has authored or co-authored more than 50 academic papers and is a consulting editor for Pediatric Research. She is a member of the American Association for the Advance ment of Science, the American Medical Association, the American Academy of Pediatrics, and the Maryland Lung Association, among others.

Johns Hopkins Children's Center's pulmonary physicians have the expertise to evaluate and treat a wide variety of problems including asthma, acute and chronic pulmonary infections, bronchopulmonary dysplasia, sleep-disordered breathing, chronic cough, cystic fibrosis, dysfunctional swallowing, end-stage lung disease, interstitial lung diseases, lung failure, and breathing abnormalities